Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety in Normal Volunteers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04249908
What this trial is testing

Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function

Who this might be right for
Renal Impairment
IlDong Pharmaceutical Co Ltd 40
Large-scale testing (Phase 3)Study completedNCT00211991
What this trial is testing

Evaluation of Consistency of StaphVAX Manufacturing Lots

Who this might be right for
Staphylococcal Infections
Nabi Biopharmaceuticals 354
Early research (Phase 1)Study completedNCT01830764
What this trial is testing

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

Who this might be right for
Acne Vulgaris
Dermira, Inc. 12
Early research (Phase 1)Study completedNCT05378997
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Who this might be right for
BlisterWound of SkinEpidermolysis Bullosa+1 more
Xinnate AB 35
Early research (Phase 1)Study completedNCT01250197
What this trial is testing

Formulation Comparison in Normal Volunteers

Who this might be right for
Normal Volunteers
Aerie Pharmaceuticals 18
Early research (Phase 1)Study completedNCT02798991
What this trial is testing

A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects

Who this might be right for
Irritable Bowel Syndrome
GlaxoSmithKline 46
Early research (Phase 1)Study completedNCT04591717
What this trial is testing

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

Who this might be right for
COVID-19
ImmunityBio, Inc. 34
Early research (Phase 1)Study completedNCT05323708
What this trial is testing

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS

Who this might be right for
Healthy Volunteers
Biocon Biologics UK Ltd 190
Early research (Phase 1)Study completedNCT01999725
What this trial is testing

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

Who this might be right for
Safety in Normal Volunteers
Enanta Pharmaceuticals, Inc 80
Early research (Phase 1)Study completedNCT00989872
What this trial is testing

Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

Who this might be right for
Skin and Soft Tissue InfectionsMethicillin-resistant Staphylococcus Aureus
Enanta Pharmaceuticals, Inc 67
Early research (Phase 1)Study completedNCT00965432
What this trial is testing

A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107

Who this might be right for
Fragile X Syndrome
Seaside Therapeutics, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00889252
What this trial is testing

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 250
Early research (Phase 1)Study completedNCT07416955
What this trial is testing

Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults

Who this might be right for
Healthy Volunteer
Kashiv BioSciences, LLC 180
Early research (Phase 1)Not Yet RecruitingNCT07140055
What this trial is testing

A Research Study to Evaluate BLX-7006 in Healthy Adults

Who this might be right for
Normal Healthy VolunteerSafety After Oral Intake
Biolexis Therapeutics 76
Early research (Phase 1)Study completedNCT01149694
What this trial is testing

Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers

Who this might be right for
Ulcerative Colitis
PurGenesis Technologies Inc. 24
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Early research (Phase 1)Study completedNCT02985437
What this trial is testing

Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin

Who this might be right for
Skin and Connective Tissue Diseases
Prof. Dr. Dr. Ursula Mirastschijski 24
Early research (Phase 1)Looking for participantsNCT06917742
What this trial is testing

Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)

Who this might be right for
Healthy VolunteersRheumatoid ArthritisSystemic Lupus Erythematosus
Capstan Therapeutics 64
Early research (Phase 1)Ended earlyNCT01934101
What this trial is testing

Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 64
Early research (Phase 1)Study completedNCT00083330
What this trial is testing

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Who this might be right for
HealthyHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Next Page